Imported medical device put into clinical use

Writer: Zhang Yu  |  Editor: Holly Wang  |  From: Shenzhen Daily  |  Updated: 2021-05-07

The magnetically controlled growing titanium rod. Courtesy of HKU-SZH

A 9-year-old boy with severe early-onset scoliosis (EOS) became the first beneficiary of the first medical equipment introduced by the University of Hong Kong-Shenzhen Hospital (HKU-SZH) under the “Hong Kong and Macao Medicine and Equipment Connect” policy, the hospital said Thursday.

It also marked the first time that the imported medical equipment, a magnetically controlled growing titanium rod, was put into clinical use on the Chinese mainland.

The boy, identified as Xiao Lei, successfully received a titanium rod implantation performed by Professor Kenneth M.C. Cheung on Monday. Cheung is the Jessie Ho Professor in spinal surgery and the head of the department of orthopedics and traumatology at the University of Hong Kong.

Xiao Lei underwent a successful surgery under the cooperation of Professor Cheung’s team and multiple medical departments Monday. Xiao Lei, who comes from a city in northern China, was diagnosed with EOS when he was 6 years old. He is now in good condition.

At the beginning of this year, after learning that the magnetically controlled growing titanium rod would soon be put into clinical use in HKU-SZH, Xiao Lei and his parents embarked on their journey to Shenzhen for treatment. Xiao Lei was admitted to the hospital April 24.

“This was our first time to Shenzhen. We came here with a glimmer of hope that he can be cured,” Xiao Lei’s mother told the hospital.

Earlier, the family was told by doctors that a traditional metal rod implantation requires multiple operations, which would greatly affect Xiao Lei’s health as he is too young.

According to Cheung, after the surgery, Xiao Lei only needs to return for follow-up visits every 2-3 months. It is expected that the titanium rod can be stretched out 1-2 months after the implantation. In the next three years, the length of the titanium rod and the angle of Xiao Lei's spine can be adjusted regularly through the instrument until he is basically recovered.

“The magnetically controlled growing rod can not only prevent the development of deformity, but also preserve the growth potential of the patient’s spine and can reduce the risks of anesthesia and wound complications,” said Cheung. “It can be said to be a disruptive innovation.”

According to HKU-SZH, four other innovative medications have also been approved and will soon be put into pilot use at the hospital.

On April 29, Rho(D) immune globulin, a blood disease drug that was the first imported medicine under the “Hong Kong and Macao Medicine and Equipment Connect” policy, was used clinically at the hospital.

网站地图 大无限彩票游戏 彩票大赢家网站 购彩网
宝马线上娱乐公司 申博娱乐真钱三公 申博138体育 澳门赌场玩法
玛雅游戏城直营网 优彩开奖网台湾宾果 网上娱乐网站 香港正版挂牌
彩票99是官方网站 易博国际娱乐平台 伟易博网址 99彩票代理
易博娱乐 彩票99官网是真是假 金巴黎彩票手机版 彩客网注册 38XTD.COM 1115118.COM XSB592.COM XSB978.COM 8JHS.COM